Literature DB >> 31505159

Epidemiology of gonorrhoea: a global perspective.

Robert D Kirkcaldy1, Emily Weston2, Aluisio C Segurado3, Gwenda Hughes4.   

Abstract

Although understanding the local epidemiology of gonorrhoea is critical for local efforts, understanding the multinational epidemiology may support development of national and international prevention and control policies and strategies. In this paper, current epidemiology of gonorrhoea is reviewed through an international lens and with a focus on selected populations. The World Health Organization (WHO) estimates that ~87 million new gonococcal infections occurred among people aged 15-49 years in 2016. Gonorrhoea rates are rising in many countries. Gay, bisexual and other men who have sex with men, racial or ethnic minorities, Indigenous populations and sex workers appear to bear disproportionate burdens of gonorrhoea. International travel can facilitate spread of gonorrhoea, including resistant strains, across international borders. Critical gaps in epidemiological knowledge are highlighted, including data on gonorrhoea among transgender persons and the burden of extragenital gonorrhoea. Even as further data are gathered, action - informed by currently available data - is needed now to confront this growing international threat.

Entities:  

Mesh:

Year:  2019        PMID: 31505159      PMCID: PMC7064409          DOI: 10.1071/SH19061

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  127 in total

1.  Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-11-22       Impact factor: 17.586

2.  Do differences in sexual behaviors account for the racial/ethnic differences in adolescents' self-reported history of a sexually transmitted disease?

Authors:  J M Ellen; S O Aral; L S Madger
Journal:  Sex Transm Dis       Date:  1998-03       Impact factor: 2.830

3.  Penicillinase-producing Neisseria gonorrhoeae.

Authors:  W A Ashford; R G Golash; V G Hemming
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

4.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.

Authors:  Vanessa G Allen; Leo Mitterni; Christine Seah; Anuradha Rebbapragada; Irene E Martin; Colin Lee; Heather Siebert; Lynn Towns; Roberto G Melano; Donald E Low
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

5.  Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Authors:  David A Lewis; Charlotte Sriruttan; Etienne E Müller; Daniel Golparian; Lindy Gumede; Donald Fick; Johan de Wet; Venessa Maseko; Jennifer Coetzee; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2013-02-14       Impact factor: 5.790

6.  High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among HIV-1 negative men who have sex with men in coastal Kenya.

Authors:  Eduard J Sanders; Alexander N Thiong'o; Haile Selassie Okuku; John Mwambi; Frances Priddy; Juma Shafi; Henry de Vries; R Scott McClelland; Susan M Graham
Journal:  Sex Transm Infect       Date:  2010-07-23       Impact factor: 3.519

7.  Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys.

Authors:  Soazig Clifton; Hikaru Bolt; Hamish Mohammed; Katy Town; Martina Furegato; Michelle Cole; Oona Campbell; Helen Fifer; Gwenda Hughes
Journal:  J Antimicrob Chemother       Date:  2018-04-01       Impact factor: 5.790

Review 8.  HIV risk and preventive interventions in transgender women sex workers.

Authors:  Tonia Poteat; Andrea L Wirtz; Anita Radix; Annick Borquez; Alfonso Silva-Santisteban; Madeline B Deutsch; Sharful Islam Khan; Sam Winter; Don Operario
Journal:  Lancet       Date:  2014-07-22       Impact factor: 79.321

9.  Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.

Authors:  Catherine A Ison; Katy Town; Chinelo Obi; Stephanie Chisholm; Gwenda Hughes; David M Livermore; Catherine M Lowndes
Journal:  Lancet Infect Dis       Date:  2013-06-11       Impact factor: 25.071

10.  Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.

Authors:  Makoto Ohnishi; Takeshi Saika; Shinji Hoshina; Kazuhiro Iwasaku; Shu-ichi Nakayama; Haruo Watanabe; Jo Kitawaki
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

View more
  29 in total

1.  The Neisseria gonorrhoeae Accessory Genome and Its Association with the Core Genome and Antimicrobial Resistance.

Authors:  Jolinda de Korne-Elenbaas; Sylvia M Bruisten; Alje P van Dam; Martin C J Maiden; Odile B Harrison
Journal:  Microbiol Spectr       Date:  2022-05-23

2.  Associations of gender identity with sexual behaviours, social stigma and sexually transmitted infections among adults who have sex with men in Abuja and Lagos, Nigeria.

Authors:  Elyse LeeVan; Fengming Hu; Andrew B Mitchell; Afoke Kokogho; Sylvia Adebajo; Eric C Garges; Haoyu Qian; Julie A Ake; Merlin L Robb; Manhattan E Charurat; Stefan D Baral; Rebecca G Nowak; Trevor A Crowell
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

3.  High proportions of rectal and pharyngeal chlamydia and gonorrhoea cases among cisgender men are missed using current CDC screening recommendations.

Authors:  Ryan D Assaf; Nicole J Cunningham; Paul C Adamson; Jamieson Trevor Jann; Robert K Bolan
Journal:  Sex Transm Infect       Date:  2022-02-25       Impact factor: 4.199

4.  Evaluation of the Hologic Aptima Combo 2 Assay for Detection of Neisseria gonorrhoeae from Joint Fluid Specimens.

Authors:  David C Alexander; Robert M Taylor; Irene Martin; Heather Adam; Philippe Lagacé-Wiens; Peter Pieroni; James A Karlowsky; Paul Van Caeseele
Journal:  J Clin Microbiol       Date:  2022-03-23       Impact factor: 11.677

Review 5.  Nanobiosystems for Antimicrobial Drug-Resistant Infections.

Authors:  Foteini Gkartziou; Nikolaos Giormezis; Iris Spiliopoulou; Sophia G Antimisiaris
Journal:  Nanomaterials (Basel)       Date:  2021-04-22       Impact factor: 5.076

6.  Within-Host Genetic Variation in Neisseria gonorrhoeae over the Course of Infection.

Authors:  Jolinda de Korne-Elenbaas; Sylvia M Bruisten; Henry J C de Vries; Alje P van Dam
Journal:  Microbiol Spectr       Date:  2022-04-25

7.  Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.

Authors:  Sami L Gottlieb; Francis Ndowa; Edward W Hook; Carolyn Deal; Laura Bachmann; Laith Abu-Raddad; Xiang-Sheng Chen; Ann Jerse; Nicola Low; Calman A MacLennan; Helen Petousis-Harris; Kate L Seib; Magnus Unemo; Leah Vincent; Birgitte K Giersing
Journal:  Vaccine       Date:  2020-04-28       Impact factor: 3.641

8.  Targeted surveillance strategies for efficient detection of novel antibiotic resistance variants.

Authors:  Allison L Hicks; Stephen M Kissler; Tatum D Mortimer; Kevin C Ma; George Taiaroa; Melinda Ashcroft; Deborah A Williamson; Marc Lipsitch; Yonatan H Grad
Journal:  Elife       Date:  2020-06-30       Impact factor: 8.140

9.  Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.

Authors:  Aliaksandra Aniskevich; Iryna Shimanskaya; Iryna Boiko; Tatyana Golubovskaya; Daniel Golparian; Iryna Stanislavova; Susanne Jacobsson; Aliaksandr Adaskevich; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2021-06-02       Impact factor: 3.090

10.  Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.

Authors:  Cecilia Ferreyra; Jennifer Osborn; Francis Moussy; Emilie Alirol; Monica Lahra; David Whiley; William Shafer; Magnus Unemo; Jeffrey Klausner; Cassandra Kelly Cirino; Teodora Wi
Journal:  PLoS One       Date:  2020-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.